BHB-T cells

Recruiting
18 years - 99 years
All
Phase N/A
20 participants needed
1 Location

Brief description of study

The aim of this study is to biobank blood and stool samples of healthy individuals receiving β-hydroxybutyrate (BHB) supplementation. Additionally, this study will determine whether BHB supplementation increases serum BHB levels and leads to changes in T cell phenotype, including composition (i.e. CD4/CD8), and cytokine secretion. BHB supplementation will be performed through oral administration of HVMN Ketone-IQ, a commercially available BHB supplement, with an active ingredient of R-1,3-Butanediol, which gets converted to BHB.

Detailed description of study

This is a preliminary study to biobank blood and stool samples following oral BHB supplementation in healthy subjects

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 18 years - 99 years
  • Gender: All

1.1               Inclusion Criteria

·         Age of 18 years or older
·         Can provide informed consent.

1.2               Exclusion Criteria

  • Subject is pregnant, a prisoner, or is under 18 years of age.
  • Subject is actively breastfeeding
  • History of autoimmune disease
  • History of inflammatory bowel disease
  • History of diabetes mellitus and are currently on medical diabetes therapy
  • History of chronic kidney disease with an eGFR < 60 mL/min/1.73m2
  • Cancer diagnosis where the subject is receiving active therapy, or cancer history within 5 years (non-melanoma skin cancers are not exclusion criteria)
  • Use of either a ketogenic diet or intermittent fasting (defined as a fasting period of 16 hours or more per day that is not associated with a medical procedure) during the 4 weeks prior to enrollment.

Updated on 17 Jun 2025. Study ID: 24-0763

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center